X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
anti-vascular endothelial growth factor (390) 390
ophthalmology (337) 337
index medicus (313) 313
humans (263) 263
ranibizumab (209) 209
bevacizumab (180) 180
male (175) 175
female (169) 169
intravitreal injections (154) 154
vascular endothelial growth factor a - antagonists & inhibitors (149) 149
aged (139) 139
macular degeneration (136) 136
vascular endothelial growth factor (131) 131
age-related macular degeneration (123) 123
eye diseases (121) 121
genetic structures (119) 119
retrospective studies (107) 107
middle aged (106) 106
tomography, optical coherence (100) 100
angiogenesis inhibitors - therapeutic use (95) 95
visual acuity (88) 88
angiogenesis inhibitors - administration & dosage (84) 84
treatment outcome (84) 84
follow-up studies (82) 82
sense organs (82) 82
aged, 80 and over (77) 77
optical coherence tomography (73) 73
fluorescein angiography (70) 70
diabetic macular edema (68) 68
aflibercept (66) 66
choroidal neovascularization (66) 66
endothelial growth-factor (65) 65
diabetic retinopathy (61) 61
photodynamic therapy (61) 61
wet macular degeneration - drug therapy (59) 59
care and treatment (55) 55
therapy (54) 54
ranibizumab - administration & dosage (53) 53
visual acuity - physiology (51) 51
time factors (50) 50
adult (45) 45
intravitreal injection (45) 45
polypoidal choroidal vasculopathy (45) 45
anti-vascular endothelial growth factor therapy (44) 44
neovascularization (44) 44
fundus oculi (43) 43
edema (41) 41
endothelial growth factors (39) 39
animals (38) 38
macular edema (38) 38
choroidal neovascularization - drug therapy (37) 37
macular edema - drug therapy (36) 36
original (36) 36
medicine & public health (35) 35
cancer (34) 34
degeneration (34) 34
health aspects (34) 34
neovascular age-related macular degeneration (34) 34
verteporfin (34) 34
analysis (33) 33
antibodies, monoclonal, humanized - therapeutic use (33) 33
research (33) 33
retina (33) 33
intravitreal bevacizumab (32) 32
patients (32) 32
physiological aspects (32) 32
outcomes (31) 31
angiogenesis (30) 30
original article (30) 30
ranibizumab - therapeutic use (30) 30
vegf (30) 30
injection (29) 29
retinopathy (29) 29
wet macular degeneration - diagnosis (29) 29
efficacy (28) 28
prospective studies (28) 28
receptors, vascular endothelial growth factor - administration & dosage (28) 28
recombinant fusion proteins - administration & dosage (28) 28
safety (28) 28
diabetes (27) 27
diabetic retinopathy - drug therapy (27) 27
intravitreal ranibizumab (27) 27
wet macular degeneration - physiopathology (27) 27
macular degeneration - drug therapy (26) 26
retinal vein occlusion (26) 26
choroidal neovascularization - diagnosis (25) 25
eye (25) 25
oncology (25) 25
risk factors (25) 25
studies (25) 25
age (24) 24
bevacizumab - administration & dosage (24) 24
endothelium (24) 24
medical imaging (24) 24
visual-acuity (24) 24
acuity (23) 23
angiogenesis inhibitors - adverse effects (23) 23
antibodies, monoclonal, humanized - administration & dosage (23) 23
medical research (23) 23
original research (23) 23
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (541) 541
Japanese (18) 18
Chinese (11) 11
Korean (10) 10
Spanish (9) 9
French (7) 7
German (7) 7
Italian (1) 1
Slovak (1) 1
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Retina, ISSN 0275-004X, 04/2011, Volume 31, Issue 4, pp. 662 - 668
Purpose: To assess the rate of infectious endophthalmitis and to describe the clinical and microbiological features of eyes that develop clinically suspected... 
VERTEPORFIN | INJECTION | SAFETY | bevacizumab | OPHTHALMOLOGY | MACULAR DEGENERATION | endophthalmitis | intravitreal injection | anti-vascular endothelial growth factor | pegaptanib | age-related macular degeneration | ranibizumab
Journal Article
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, ISSN 0275-004X, 08/2019, Volume 39, Issue 8, pp. 1519 - 1526
Journal Article
Journal Article
European journal of ophthalmology, ISSN 1120-6721, 03/2018, Volume 28, Issue 2, pp. 256 - 258
Purpose: To describe a case of unilateral acute idiopathic maculopathy (UAIM) response to intravitreal therapy with aflibercept (Eylea). Methods: Retrospective... 
Unilateral acute idiopathic maculopathy | Aflibercept | Anti-vascular endothelial growth factor | OPHTHALMOLOGY
Journal Article
Retina (Philadelphia, Pa.), ISSN 0275-004X, 09/2018, Volume 38, Issue 9, pp. 1801 - 1808
Purpose: The aim of this study was to investigate the changes in plasma vascular endothelial growth factor (VEGF) level depending on the severity of diabetic... 
FACTOR VEGF | EFFICACY | aflibercept | SAFETY | AQUEOUS-HUMOR | RISK | intravitreal injection | diabetic retinopathy | CANCER | ranibizumab | DEGENERATION | arterial thromboembolic events | PHARMACOKINETICS | plasma vascular endo-thelial growth factor level | vascular endothelial growth factor | bevacizumab | OPHTHALMOLOGY | RETINOPATHY | VITREOUS LEVELS | anti-vascular endothelial growth factor agents | diabetic macular edema | Diabetic Retinopathy - drug therapy | Prospective Studies | Follow-Up Studies | Intravitreal Injections | Humans | Middle Aged | Male | Vascular Endothelial Growth Factor A - antagonists & inhibitors | Diabetic Retinopathy - complications | Dose-Response Relationship, Drug | Macular Edema - etiology | Angiogenesis Inhibitors - administration & dosage | Female | Drug Therapy, Combination | Recombinant Fusion Proteins - administration & dosage | Macula Lutea - pathology | Severity of Illness Index | Bevacizumab - administration & dosage | Enzyme-Linked Immunosorbent Assay | Tomography, Optical Coherence | Vascular Endothelial Growth Factor A - blood | Treatment Outcome | Biomarkers - blood | Macular Edema - blood | Receptors, Vascular Endothelial Growth Factor - administration & dosage | Diabetic Retinopathy - blood | Macular Edema - drug therapy | Ranibizumab - administration & dosage | Diabetic retinopathy | Eye diseases | Care and treatment | Vascular endothelial growth factor | Health aspects | Index Medicus | Original Study | anti–vascular endothelial growth factor agents | plasma vascular endothelial growth factor level
Journal Article
Journal Article
Journal Article
Acta Ophthalmologica, ISSN 1755-375X, 11/2016, Volume 94, Issue 7, pp. 646 - 651
Journal Article
by Kim, JH and Chang, YS and Kim, JW and Kim, CG and Lee, DW and Kim, YJ
RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, ISSN 0275-004X, 11/2018, Volume 38, Issue 11, pp. 2168 - 2176
Journal Article
Retina (Philadelphia, Pa.), ISSN 0275-004X, 04/2019, Volume 39, Issue 4, pp. 712 - 718
Using optical coherence tomography (OCT) angiography to assess the therapeutic effect of intravitreal anti-vascular endothelial growth factor on myopic... 
optical coherence tomography angiography | choroidal neovascularization area | SECONDARY | OPHTHALMOLOGY | MACULAR DEGENERATION | anti-vascular endothelial growth factor | RANIBIZUMAB | myopic choroidal neovascularization
Journal Article
Journal Article